Two sisters raise $3,500 for pancreatic cancer research
11-year-old Everly and 9-year-old Charlotte Hartley are honouring their grandmother's legacy, who passed away from stage four pancreatic cancer last year.
'She was awesome,' said Everly. 'We liked making cookies together and a whole lot of fun stuff like that.'
Soon after their grandmother's passing, the sisters decided to take their love of animals and use it to 'make a difference.'
'She was an animal lover like us,' said Everly. 'We decided to make dog bandanas.'
The pair sold their creations for 10 dollars each, donating every cent to the Baker Centre for Pancreatic Cancer at London Health Sciences Centre, the same place their grandmother received care.
They have raised over $3,500.
'I wanted to get the money fast enough to get more research for her,' said Everly. 'We didn't, but I am happy we can help some people.'
Both Everly and Charlotte agreed that donating for cancer research is an 'important thing' and they both 'really like helping people.'
They say they hope their efforts will 'lead to better outcomes' for patients in the future.
When asked what the girls thought their grandmother would have to say about their work, Charlotte said she thinks she would be 'proud.'
'She would be happy we did this and that we did it for her,' said Charlotte.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
an hour ago
- CBC
It's time to ramp up efforts to prevent tick-borne illnesses, scientists say
"I know it's not stylish," admits Nicholas Ogden, "but it actually does prevent the ticks." He tucks his pants into his socks, then sprays insect repellant over both. The scientist is preparing to test a section of Mont-Saint Bruno, a hill in southern Quebec, for ticks — without catching the diseases they carry. Today, he's got a special eye out for black-legged tick nymphs. At this stage, they're about as big as a poppy seed, and they're the most likely suspects carrying bacteria and parasites that cause maladies like Lyme disease, anaplasmosis or babesiosis. With warmer temperatures, ticks have been taking root in places they never have before. And Ogden, a senior scientist at the Public Health Agency of Canada (PHAC), thinks it's only going to get worse. "The studies that we've done suggest it still has a way to go. The ticks are still continuing to spread their geographic range," said Ogden, who has studied ticks for decades. "What it does show," he says, "is that climate change is having an impact on our health." Now, Canadian scientists are trying to get ahead of the trend — researching new, experimental ways to control tick populations, and calling for new prevention methods. National tick surveillance As tick populations have increased, so have the number of people falling ill with tick-borne diseases across Canada, says Dr. Gerald Evans, an infectious diseases expert at Queen's University in Kingston, Ont. "We continue to see more and more cases," he said. "We principally see people with anaplasmosis in the spring, but we do see Lyme disease all throughout the year, but principally in the spring and the summer." Negar Elmieh, a scientist with the National Collaborating Centre for Environmental Health, says there's more that all levels of government can do to comprehensively track tick populations across Canada. That could include a comprehensive countrywide system that allows scientists to see what ticks are where. "There's some of that going on in pockets of Canada, but there's not a national system of comprehensive tick surveillance," she said. Ogden from PHAC said tick surveillance across Canada has already ramped up quite a bit in the past two decades, as tick populations have increased. According to the health agency's last report tracking ticks, authorities tracked the arachnids through images or samples collected from people or their pets, submitted voluntarily by members of the public, veterinarians or health-care workers. The report also looked at the ticks collected from their natural habitat by researchers, through methods like drag sampling (dragging fabric along the forest ground, and seeing what kind of ticks latch on) from 331 sites in 10 provinces. Through that data, it found that in provinces like Quebec and Ontario, about one in four blacklegged ticks carried the bacteria that causes Lyme disease. Targeting deer and white footed-mice Researchers are also looking to curb the tick population by targeting the animals on which they feed. One system that's been used in the U.S. focuses on deer. Called a "4-Poster treatment," it involves strategically placing deer feed near rollers soaked in tick-killing chemicals. "As the deer are eating, their legs are rubbing against these rollers, which are applying the pesticides to them," says Elmieh. WATCH | What to look out for as tick-borne illnesses rise: Tick borne illnesses are on the rise. Here's what to look out for 21 days ago Dr. Samir Gupta, a Toronto based respirologist, is warning of an increase in tick bites and tick-borne illnesses across Canada. Ticks are parasites that feed on the blood of wild animals, and are known to transmit bacteria through bites. However, Ogden says these systems haven't been effective in every location. "In some places, very few deer actually come to the feeders, so it depends from one place to another," Ogden said, citing research from colleagues on the system's effectiveness in the Maritimes. "That is why it's still a research project." Quebec is exploring a similar treatment, but targeting mice and other rodents, not deer. Called "reservoir-targeted methods," it tries to reduce the transmission of the pathogens that cause the diseases among animals like white-footed mice, rats and chipmunks. That could mean putting bait into a station that contains tick-killing pesticides called acaricides. "So when a mouse goes in and eats one of those baits, it acquires a dose of acaricide, which gets onto the surface of the mouse and kills the ticks." Smart landscaping Tucking your pants into your socks, using insect repellent like DEET or Icaridin, and thoroughly checking your body for ticks after spending time outdoors are established ways to prevent tick-borne diseases. Another way people can reduce risk, Elmieh says, is by being smart about how their backyards or recreational areas are set up. WATCH | Protecting pets from ticks: How to protect your pets from ticks this summer 13 hours ago Dr. Lauren Adelman, a veterinarian, internal medicine specialist and co-founder of The Senior Dog Veterinary Society, says she's been seeing more dogs come into her practice with ticks. She tells BC Today Michelle Eliot owners should give their pets a head-to-toe tick check after walks, and take the animal to a vet if a tick is found. "Ticks don't like hard surfaces, so using [hardscaping] material — concrete, rock, wood chips, gravel — is great for walkways and gathering areas, because ticks don't like to crawl on that." Another way to curb tick populations, Elmieh says: pruning trees and bushes and maintaining lawns. That, she says, reduces humidity and increases sunlight, which ticks don't like. People can also add garden plants that deer and rodents are less likely to be attracted to, like lavender, Russian sage, pennyroyal, irises and daffodils.
CTV News
6 hours ago
- CTV News
Knee surgery changes course of common knee problem, according to local researchers
London-based study shows that a specialized knee surgery can prevent knee replacement. CTV's Reta Ismail has more. Researchers at Western have made significant progress treating a common knee issue, allowing some to avoid knee replacement. People suffering with knee osteoarthritis, a condition which brings pain, stiffness and sometimes the need for joint replacement surgery, can undergo a surgical operation called high tibial osteotomy. 'So in the surgery, they'll take that maligned limb, so that bowed limb, and actually straighten it to shift loads away from the most damaged compartment of the knee,' said Dr. Trevor Birmingham, professor and Canada research chair in musculoskeletal rehabilitation in Western's faculty of health sciences. The study is led by researchers at Western University and the Fowler Kennedy Sport Medicine Clinic. A two-year clinical trial followed 145 patients and compared those who had HTO and non-surgical therapy with those who only had therapy. The results showed that HTO slowed joint damage, reduced pain and improved movement. This is the first real evidence that a treatment can cand the course of osteoarthritis. The surgery is less common than joint replacement, but the researchers believe it needs more attention to help people in their 50s with specific alignment issues. - With files from CTV's Reta Ismail
National Post
21 hours ago
- National Post
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
Article content Phase 3 data show Bausch + Lomb's LUMIFY Preservative Free eye drops are as safe and effective as the original LUMIFY in reducing ocular redness The multicenter study with 380 participants confirmed that LUMIFY Preservative Free eye drops are non-inferior in efficacy to the original LUMIFY and have a favorable safety profile, offering an effective preservative-free option for sensitive eyes LUMIFY delivers noticeable results in one minute, lasts up to eight hours and is the No. 1 doctor-recommended redness reliever brand; more info at Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever eye drops for reducing ocular redness. Article content 'Since launching in 2018, LUMIFY has been the No. 1 doctor-recommended redness reliever brand, known for delivering noticeable results in one minute and lasting up to eight hours,' 1 said John Ferris, president, Consumer, Bausch + Lomb. 'This study demonstrates that our new LUMIFY Preservative Free eye drops reduce redness quickly and are just as safe and effective as the original LUMIFY, providing a needed option for patients with eye sensitivities.' Article content In the randomized, active-controlled, multicenter study, 380 participants with ocular redness received either LUMIFY Preservative Free or LUMIFY, administered as a single drop four times daily for four weeks. The primary objective was to demonstrate that LUMIFY Preservative Free is non-inferior to LUMIFY in reducing ocular redness. The primary efficacy endpoint was investigator-assessed ocular redness score at eight timepoints from five-minutes to 240-minutes after drop administration on day one. The secondary objective of the study was to compare the safety of LUMIFY Preservative Free and LUMIFY. Article content The study met its primary objective, confirming that LUMIFY Preservative Free is statistically non-inferior to LUMIFY in reducing ocular redness in adults. A day one analysis of all 11 time points (one minute to 480 minutes post-administration) further supported these findings; and additional secondary efficacy endpoint data from one minute, 360 minutes and 480 minutes post-administration demonstrated that LUMIFY Preservative Free performs similarly to LUMIFY. The overall safety profile of LUMIFY Preservative Free was favorable and comparable to LUMIFY, and the occurrence of ocular treatment-emergent adverse events was similar in both treatment groups. In this clinical trial, LUMIFY Preservative Free demonstrated to have a low incidence of side effects, like rebound redness and loss of efficacy over time, when used as directed. Article content 'The results show that LUMIFY Preservative Free is a well-tolerated alternative option for consumers with ocular redness who have sensitivities to preservatives or are at increased risk of ocular surface disease,' said Melissa Toyos, MD, and partner, Toyos Clinic, Nashville, TN. Article content About the LUMIFY Brand Article content The LUMIFY brand began in 2018 with the U.S. launch of LUMIFY redness reliever eye drops. Before LUMIFY, redness relievers relied on the same ingredients for decades and were associated with well-known side effects. LUMIFY and LUMIFY Preservative Free are the only over-the-counter redness relievers formulated with low-dose brimonidine tartrate 0.025% that selectively target eye redness and offer excellent results with a lower risk of rebound redness and loss of efficacy when used as directed. In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS™, a line of specialty eye care products specifically developed for the sensitive area around the eyes. In June 2025, Bausch + Lomb launched LUMIFY Preservative Free eye drops in the U.S. For more information on the LUMIFY brand, visit Article content Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit Article content Facebook Article content , Article content Instagram Article content , Article content LinkedIn Article content , Article content X Article content and Article content YouTube Article content . Article content References Article content ©2025 Bausch + Lomb. Article content Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Kristy Marks Article content Article content Article content
